Literature DB >> 33405631

Naproxen Nanoparticle-Loaded Thermosensitive Chitosan Hydrogel for Prevention of Postoperative Adhesions.

Yu Wang1,2, XianLun Pang3, Jia Luo1, Qian Wen1, ZhouXue Wu1, QiuXia Ding4, Ling Zhao5, LingLin Yang1, BiQiong Wang1, ShaoZhi Fu1.   

Abstract

Postoperative adhesions are the most common complications of peri-abdominal surgery; they not only affect the patient's quality of life but also increase the risk of a subsequent surgery. The use of implantable dressings to physically block surgical wounds is the primary solution to prevent postoperative adhesions. In this study, we prepared naproxen nanoparticles that were loaded with chitosan hydrogel (CS/Nap hydrogel) to prevent postoperative adhesions. Our data confirmed that the prepared CS/Nap hydrogel was thermosensitive and suitable for injection. The efficacy of anti-adhesion in a rat model revealed that the hydrogel effectively separated from the wounds of the abdominal wall and cecum. On day 7 postsurgery, the wounds were completely covered by a new epithelial layer, whereas wounds in the negative control group were glued together. Additionally, the in vivo toxicity study showed that the CS/Nap hydrogel had fewer toxic and side effects on major tissues and organs, including the liver, spleen, heart, lung, and kidney. We showed that a drug delivery system based on CS/Nap hydrogel has the potential not only to prevent postoperative abdominal adhesions and relieve pain but also to contribute to the administration of the hydrophobic drug naproxen.

Entities:  

Keywords:  chitosan; nanoparticle; naproxen; postoperative adhesion; thermosensitive hydrogel

Year:  2019        PMID: 33405631     DOI: 10.1021/acsbiomaterials.8b01562

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  1 in total

1.  Self-assembled dihydroartemisinin nanoparticles as a platform for cervical cancer chemotherapy.

Authors:  Yun Lu; Qian Wen; Jia Luo; Kang Xiong; ZhouXue Wu; BiQiong Wang; Yue Chen; Bo Yang; ShaoZhi Fu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.